Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院附設醫院 (臺大醫院)
/
影像醫學部
CHIH-WEI YU
研究人員網路
瀏覽統計
Email 通知
RSS Feed
簡歷
研究成果
37
計畫
3
研究成果
(全部)
全部
期刊文章
回顧型論文
其他
顯示/隱藏過濾條件
依作者
5
chih-wei yu
5
tiffany ting-fang shih
4
chao-yu hsu
3
chih-hung hsu
3
chiun hsu
3
wei s.-y.
2
chen b.-b.;hsu c.-y.;yu c.-w.;liang p.-c.;hsu c.;chih-hung hsu;cheng a.-l.;shih t.t.-f.
2
ching-hung lin
2
po-chin liang
2
wei-wu chen
.
下一頁 >
主題
5
[sdgs]sdg3
1
bevacizumab; biological marker; choline; cisplatin; creatine; epidermal growth factor receptor 2; etoposide; gadobutrol; n acetylaspartic acid; antineoplastic agent; aspartic acid; choline; creatinine; n-acetylaspartate; tumor marker; adult; aged; apparent diffusion coefficient; article; brain metastasis; breast cancer; cancer chemotherapy; cancer survival; clinical article; clinical outcome; diffusion weighted imaging; dynamic contrast-enhanced magnetic resonance imaging; female; follow up; human; multiparametric magnetic resonance imaging; nuclear magnetic resonance imaging; nuclear magnetic resonance spectroscopy; overall survival; priority journal; progression free survival; prospective study; protein expression; analogs and derivatives; brain tumor; breast tumor; diagnostic imaging; kaplan meier method; middle aged; mortality; pathology; procedures; proportional hazards model; secondary; adult; aged; antineoplastic agents; aspartic acid; biomarkers, tumor; brain neoplasms; breast neoplasms; choline; creatinine; female; humans; kaplan-meier estimate; magnetic resonance imaging; magnetic resonance spectroscopy; middle aged; proportional hazards models; prospective studies
1
bevacizumab; cisplatin; epidermal growth factor receptor 2; estrogen receptor; etoposide; angiogenesis inhibitor; antineoplastic agent; bevacizumab; cisplatin; contrast medium; etoposide; adult; aged; article; brain metastasis; breast cancer; cancer survival; clinical article; contrast enhancement; dynamic contrast enhanced magnetic resonance imaging; human; multicenter study (topic); multiple cycle treatment; nuclear magnetic resonance imaging; phase 2 clinical trial (topic); pilot study; prospective study; tumor vascularization; tumor volume; brain neoplasms; breast neoplasms; clinical trial; diagnostic imaging; drug administration; drug resistance; female; middle aged; pathology; phase 2 clinical trial; procedures; secondary; time factor; treatment outcome; vascularization; adult; aged; angiogenesis inhibitors; antineoplastic combined chemotherapy protocols; bevacizumab; brain neoplasms; breast neoplasms; cisplatin; contrast media; drug administration schedule; drug resistance, neoplasm; etoposide; female; humans; magnetic resonance imaging; middle aged; pilot projects; prospective studies; time factors; treatment outcome
1
gadodiamide; placebo; sorafenib; tegafur; uracil; vandetanib; antineoplastic agent; contrast medium; gadolinium pentetate; adult; advanced cancer; age; aged; cancer chemotherapy; cancer mortality; cancer prognosis; cancer survival; comparative study; controlled study; disease association; dynamic contrast-enhanced magnetic resonance imaging; female; gender; human; liver cell carcinoma; liver parenchyma; major clinical study; male; overall survival; phase 2 clinical trial (topic); portal vein thrombosis; priority journal; retrospective study; review; risk factor; survival time; systemic therapy; tumor volume; carcinoma, hepatocellular; diagnostic imaging; liver neoplasms; middle aged; nuclear magnetic resonance imaging; pathology; procedures; survival rate; treatment outcome; very elderly; adult; aged; aged, 80 and over; antineoplastic combined chemotherapy protocols; carcinoma, hepatocellular; contrast media; gadolinium dtpa; humans; liver neoplasms; magnetic resonance imaging; middle aged; retrospective studies; survival rate; treatment outcome
1
placebo; sorafenib; uft; vandetanib; contrast medium; adult; advanced cancer; aged; antiangiogenic activity; area under the curve; article; cancer chemotherapy; cancer patient; cancer prognosis; cancer survival; clinical outcome; controlled study; dynamic contrast-enhanced magnetic resonance imaging; fatality; female; human; image analysis; kaplan meier method; liver cell carcinoma; major clinical study; male; overall survival; perfusion; priority journal; retrospective study; systemic therapy; cancer staging; disease exacerbation; follow up; liver cell carcinoma; liver circulation; liver tumor; magnetic resonance angiography; middle aged; multimodality cancer therapy; physiology; predictive value; prevalence; procedures; survival rate; taiwan; time factor; trends; vascularization; very elderly; young adult; adult; aged; aged, 80 and over; carcinoma, hepatocellular; combined modality therapy; contrast media; disease progression; female; follow-up studies; humans; liver circulation; liver neoplasms; magnetic resonance angiography; male; middle aged; neoplasm staging; predictive value of tests; prevalence; survival rate; taiwan; time factors; young adult
1
sorafenib; uft; adult; aged; article; blood vessel reactivity; cancer survival; clinical article; dynamic contrast enhanced magnetic resonance imaging; female; human; liver cell carcinoma; male; nuclear magnetic resonance imaging; outcome assessment; overall survival; phase 2 clinical trial (topic); priority journal; progression free survival; survival rate; survival time; treatment response; adult; aged; aged, 80 and over; antimetabolites, antineoplastic; antineoplastic agents; antineoplastic combined chemotherapy protocols; benzenesulfonates; biological markers; carcinoma, hepatocellular; contrast media; feasibility studies; female; humans; liver neoplasms; magnetic resonance imaging; male; middle aged; neovascularization, pathologic; predictive value of tests; pyridines; tegafur; uracil; young adult
依日期
5
2011 - 2019
依類型
4
journal article
1
review
全文
5
no fulltext
關閉過濾條件
再查詢
作者:
ann-lii cheng
作者:
bang-bin chen
第 1 到 5 筆結果,共 5 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2018
Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer
BANG-BIN CHEN
; YEN-SHEN LU
; CHIH-WEI YU
; CHING-HUNG LIN
; WEI-WU CHEN
; Wei S.-Y.; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
European Radiology
9
9
2
2017
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
BANG-BIN CHEN
; CHAO-YU HSU
; CHIH-WEI YU
; PO-CHIN LIANG
; CHIUN HSU
; CHIH-HUNG HSU
; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
European Radiology
15
17
3
2016
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
BANG-BIN CHEN
; YEN-SHEN LU
; CHING-HUNG LIN
; WEI-WU CHEN
; Wu P.-F.; CHAO-YU HSU
; CHIH-WEI YU
; Wei S.-Y.; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
BMC Cancer
20
17
4
2016
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
BANG-BIN CHEN
; CHAO-YU HSU
; CHIH-WEI YU
; PO-CHIN LIANG
; CHIUN HSU
; CHIH-HUNG HSU
; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Radiology
27
25
5
2011
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
CHAO-YU HSU
; Ying-Chun Shen
; CHIH-WEI YU
; CHIUN HSU
; Hu F.-C.; CHIH-HUNG HSU
; BANG-BIN CHEN
; Wei S.-Y.; ANN-LII CHENG
; TIFFANY TING-FANG SHIH
Journal of Hepatology
106
100
申請連結研究人員資料
以 ORCID 登入申請連結此個人資料
ORCID Login
Contact via feedback form
若您要聯絡網站管理員,請點選以下按鈕